Who
Harry Thomasian Jr.
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, Precigen.
In numbers
- Trades disclosed
- 86
- Buys
- 5
- Sells
- 9
- Bought
- $242K
- Sold
- $3.9M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 18 Oct 2021
- Last trade
- 23 Sep 2026
- Last filed
- 24 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 23 Sep 2026filed 24 Sep 2026 | PGEN PrecigenBiotechnology | SEC FORM 4 Code M | $51K10,744 at $4.72 | filing |
| 23 Sep 2026filed 24 Sep 2026 | PGEN PrecigenBiotechnology | SEC FORM 4 Code M | $100K42,918 at $2.33 | filing |
| 23 Sep 2026filed 24 Sep 2026 | PGEN PrecigenBiotechnology | SEC FORM 4 Code M | $22 at $0.96 | filing |
| 23 Sep 2026filed 24 Sep 2026 | PGEN Precigenoption or derivative · Biotechnology | SEC FORM 4 Code M | —10,744 at $0.00 | filing |
| 23 Sep 2026filed 24 Sep 2026 | PGEN Precigenoption or derivative · Biotechnology | SEC FORM 4 Code M | —42,918 at $0.00 | filing |
| 23 Sep 2026filed 24 Sep 2026 | PGEN Precigenoption or derivative · Biotechnology | SEC FORM 4 Code M | —2 at $0.00 | filing |
| 23 Sep 2026filed 24 Sep 2026 | PGEN Precigenoption or derivative · Biotechnology | SEC FORM 4 Code M | —1 at $0.00 | filing |
| 23 Sep 2026filed 24 Sep 2026 | PGEN PrecigenBiotechnology | SEC FORM 4 Code M | $11 at $1.21 | filing |
| 23 Sep 2026filed 24 Sep 2026 | PGEN Precigenoption or derivative · Biotechnology | SEC FORM 4 Code M | —10,744 at $0.00 | filing |
| 23 Sep 2026filed 24 Sep 2026 | PGEN Precigenoption or derivative · Biotechnology | SEC FORM 4 Code M | —42,918 at $0.00 | filing |
| 23 Sep 2026filed 24 Sep 2026 | PGEN Precigenoption or derivative · Biotechnology | SEC FORM 4 Code M | —2 at $0.00 | filing |
| 23 Sep 2026filed 24 Sep 2026 | PGEN Precigenoption or derivative · Biotechnology | SEC FORM 4 Code M | —1 at $0.00 | filing |
| 23 Sep 2026filed 24 Sep 2026 | PGEN PrecigenBiotechnology | SEC FORM 4 Code M | $51K10,744 at $4.72 | filing |
| 23 Sep 2026filed 24 Sep 2026 | PGEN PrecigenBiotechnology | SEC FORM 4 Code M | $100K42,918 at $2.33 | filing |
| 23 Sep 2026filed 24 Sep 2026 | PGEN PrecigenBiotechnology | SEC FORM 4 Code M | $22 at $0.96 | filing |
| 23 Sep 2026filed 24 Sep 2026 | PGEN PrecigenBiotechnology | SEC FORM 4 Code M | $11 at $1.21 | filing |
| 23 Aug 2026filed 25 Aug 2026 | PGEN PrecigenBiotechnology | SEC FORM 4 Code M | —7,291 | filing |
| 23 Aug 2026filed 25 Aug 2026 | PGEN PrecigenBiotechnology | SEC FORM 4 Code F | $26K3,577 at $7.20 | filing |
| 23 Aug 2026filed 25 Aug 2026 | PGEN Precigenoption or derivative · Biotechnology | SEC FORM 4 Code M | —7,291 at $0.00 | filing |
| 23 Aug 2026filed 25 Aug 2026 | PGEN Precigenoption or derivative · Biotechnology | SEC FORM 4 Code M | —7,291 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.